ADVERTISEMENT
ADVERTISEMENT

1

Patients infected with HIV have highly variable CD8+ CTL responses despite the high number of circulating CD8+ T cells, an observation that remains poorly understood. In March Journal of Immunology Mohammed Garba and colleagues from University of North Carolina, Chapel Hill, USA, show that the failure of CD8+ T cell responses can be the result of an active HIV regulatory process mediated by secretion of TGF-β1, rather than the absence of CD8+ cells.Garba et al. used flow cytometric methods

Tudor Toma(t.toma@ic.ac.uk)

Patients infected with HIV have highly variable CD8+ CTL responses despite the high number of circulating CD8+ T cells, an observation that remains poorly understood. In March Journal of Immunology Mohammed Garba and colleagues from University of North Carolina, Chapel Hill, USA, show that the failure of CD8+ T cell responses can be the result of an active HIV regulatory process mediated by secretion of TGF-β1, rather than the absence of CD8+ cells.

Garba et al. used flow cytometric methods and measured intracellular cytokines such as TGF-β1 and IFN-γ in lymphocytes from HIV+ donors. They found that numerous HIV proteins or peptides could induce in vitro TGF-β1 secretion by CD8+T cells that is capable of inhibiting the IFN-γ response to HIV and other unrelated vaccinia virus proteins (J Immunol 2002, 168:2247-2254).

These results show a new...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
ADVERTISEMENT